Skip to content
Ejaculation.org

Meta-analysis · 2011

Efficacy and safety of dapoxetine for the treatment of premature ejaculation: integrated analysis of results from five phase 3 trials

McMahon CG, Althof SE, Kaufman JM, Buvat J, Levine SB, Aquilina JW, Tesfaye F, Rothman M, Rivas DA, Porst H (2011). Efficacy and safety of dapoxetine for the treatment of premature ejaculation: integrated analysis of results from five phase 3 trials. The Journal of Sexual Medicine. doi:10.1111/j.1743-6109.2010.02097.x

Key finding
Across five placebo-controlled trials (6,081 men), on-demand dapoxetine raised average latency from 0.9 minutes to 3.1 (30 mg) and 3.6 minutes (60 mg) at 12 weeks, versus 1.9 on placebo; nausea, dizziness and headache were most common.

Summary

Dapoxetine is a short-acting SSRI (selective serotonin reuptake inhibitor) developed to be taken on demand, 1 to 3 hours before sex. This integrated analysis pooled five randomised, double-blind, placebo-controlled phase 3 trials in more than 25 countries, involving 6,081 men aged 18 or older who met DSM-IV-TR criteria for premature ejaculation (four trials also required a baseline latency of 2 minutes or less). Dapoxetine 30 mg and 60 mg were tested for 12 or 24 weeks.

At week 12, mean intravaginal ejaculatory latency time (IELT) rose from about 0.9 minutes at baseline to 3.1 minutes with 30 mg and 3.6 minutes with 60 mg, compared with 1.9 minutes on placebo (geometric mean fold increases of 2.5, 3.0 and 1.6). Ratings of control, satisfaction and distress, and clinicians' global impression, improved significantly more than with placebo. The most common side effects were nausea, dizziness and headache. Validated questionnaires showed no signals of anxiety, restlessness (akathisia), suicidality or mood change, and no withdrawal syndrome on stopping.

Limitations

These were the phase 3 trials of the drug's development programme; check the full paper for funding and author disclosures. Average results hide wide individual variation, and the placebo group also improved substantially, which shows how much expectation and attention matter. Effects last only while the drug is taken. Dapoxetine is not approved in the United States.

What it means for you

Dapoxetine produces a real but moderate average gain, from under 1 minute to around 3 to 3.5 minutes in these trials, when taken before sex. It requires a prescription and a discussion of side effects and interactions with your doctor. It can be used alongside behavioural training.